Helen Williams
Tracked across 1 events · 7 articles · First seen Mar 31, 2026 · Last active Apr 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Helen Williams, national clinical director for cardiovascular disease prevention at United Kingdom — National Health Service England, highlighted the life-changing potential of semaglutide for high-risk patients.
Mar 31, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Helen Williams live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard